JAADi-Supplementary Materials-Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis

Name: JAADi-Supplementary Materials-Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis
Creator: Yoshiki Okada
Published: 2025-11-20T13:23:50.259Z
Keywords: Dermatology, Atopic Dermatitis

Okada, Yoshiki; Kamata, Masahiro; Suzuki, Shoya; Watanabe, Ayu; Chijiwa, Chika; Tomura, Yayoi; Takeshima, Ryosuke; Hiura, Azusa; Hayashi, Kotaro; Fukuyasu, Atsuko; Tanaka, Takamitsu; Ishikawa, Takeko; Tada, Yayoi

doi:10.17632/ftrzwhz67t.1

JAADi-Supplementary Materials-Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis

Published: 20 November 2025| Version 1 | DOI: 10.17632/ftrzwhz67t.1

Contributors:

Yoshiki Okada, Masahiro Kamata, Shoya Suzuki, Ayu Watanabe, Chika Chijiwa, Yayoi Tomura, Ryosuke Takeshima, Azusa Hiura, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Yayoi Tada

Description

JAAD International Supplementary Materials Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis

Files

Institutions

Teikyo Daigaku Igakubu Daigakuin Igaku Kenkyuka

JAADi-Supplementary Materials-Okada Y et al. Real-world effectiveness and safety of every-four-week lebrikizumab maintenance dosing from Week 4 following two loading doses in Japanese patients with atopic dermatitis

Description

Files

Institutions

Categories

Licence